Investigative Ophthalmology & Visual Science, Vol 35, 2924-2931, Copyright © 1994 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Activin expression by cultured human retinal pigment epithelial cells

GJ Jaffe, CE Harrison, GM Lui, WL Roberts, PC Goldsmith, S Mesiano and RB Jaffe
Department of Ophthalmology, Duke University, Durham, North Carolina 27710.

PURPOSE. To determine whether human retinal pigment epithelial (hRPE) cells produce activin, a growth factor in the transforming growth factor beta family, and to characterize growth regulatory effects of activin on retinal pigment epithelium. METHODS. mRNA expression was examined using polymerase chain reaction with primers specific for the beta A and beta B chains of activin and by slot blot analysis with a probe specific for the beta A chain. Protein localization was determined immunocytochemically using antibodies specific for the beta A chain of activin and intact activin A. The effect of activin A on DNA synthesis was studied by measuring (3H) thymidine incorporation after cells were exposed to recombinant human activin A (rhA). Growth regulatory effects of rhA on hRPE cells were examined with cell growth assays. RESULTS. beta A mRNA was expressed constitutively in 8/8 cells lines tested. beta B mRNA was not expressed in any of the six cell lines tested but was expressed in human ovarian granulosa cell controls. Positive immunostaining was observed for both the beta A chain and intact activin A. (3H) thymidine incorporation was inhibited 44% (P < 0.025), 45% (P < 0.025), and 44% (P < 0.015) when RPE cells were exposed to 100 ng/ml rhA and grown in serum-free medium, medium with 0.5% serum, and 1% serum, respectively. Cell growth was inhibited 33.2% (P = 0.0001) after RPE cells were exposed to 100 ng/ml rhA for 8 days. CONCLUSIONS: These results suggest that activin A can act as an autocrine-paracrine growth regulator in RPE cells and may help control cellular growth in ocular development and proliferative eye disease.

This article has been cited by other articles:

				V. Poulaki, N. Mitsiades, F. E. Kruse, S. Radetzky, E. Iliaki, B. Kirchhof, and A. M. Joussen Activin A in the Regulation of Corneal Neovascularization and Vascular Endothelial Growth Factor Expression Am. J. Pathol., April 1, 2004; 164(4): 1293 - 1302. [Abstract] [Full Text] [PDF]

				P. Yang, B. S. McKay, J. B. Allen, W. L. Roberts, and G. J. Jaffe Effect of Mutant I{kappa}B on Cytokine-Induced Activation of NF-{kappa}B in Cultured Human RPE Cells Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1339 - 1347. [Abstract] [Full Text] [PDF]

				Y.-G. Chen, H. M. Lui, S.-L. Lin, J. M. Lee, and S.-Y. Ying Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin Experimental Biology and Medicine, February 1, 2002; 227(2): 75 - 87. [Abstract] [Full Text] [PDF]

				L. You and F. E. Kruse Differential Effect of Activin A and BMP-7 on Myofibroblast Differentiation and the Role of the Smad Signaling Pathway Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 72 - 81. [Abstract] [Full Text] [PDF]

				S Fuhrmann, E. Levine, and T. Reh Extraocular mesenchyme patterns the optic vesicle during early eye development in the embryonic chick Development, January 11, 2000; 127(21): 4599 - 4609. [Abstract] [PDF]